Provided by Tiger Trade Technology Pte. Ltd.

Kyverna Therapeutics

6.91
-3.3300-32.52%
Post-market: 7.100.1900+2.75%19:59 EST
Volume:15.58M
Turnover:112.15M
Market Cap:302.63M
PE:-1.86
High:7.41
Open:6.91
Low:6.72
Close:10.24
52wk High:13.67
52wk Low:1.78
Shares:43.80M
Float Shares:22.47M
Volume Ratio:3.38
T/O Rate:69.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7205
EPS(LYR):-3.3254
ROE:-70.82%
ROA:-40.75%
PB:1.99
PE(LYR):-2.08

Loading ...

Company Profile

Company Name:
Kyverna Therapeutics
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
129
Office Location:
5980 Horton Street,Suite 550,Emeryville,California,United States
Zip Code:
94608
Fax:
- -
Introduction:
- -

Directors

Name
Position
Ian Clark
Chairman of the Board
Warner Weston Biddle
Chief Executive Officer and Director
Beth Seidenberg
Independent Director
Christi Shaw
Independent Director
Daniel K. Spiegelman
Independent Director
Fred E. Cohen
Independent Director
Mert Aktar
Independent Director

Shareholders

Name
Position
Warner Weston Biddle
Chief Executive Officer and Director
Marc Grasso
Chief Financial Officer and Principal Accounting Officer
Karen Walker
Chief Technology Officer
Naji H. Gehchan
Chief Medical and Development Officer